Evaluation of the quo-test hemoglobin A1c point-of-care instrument: Second chance

Clinical Chemistry

Volumn 56, Issue 7, 2010, Pages 1191-1193

  Lenters Westra, Erna ^a,b   Slingerland, Robbert J ^a,b  

^a ISALA HOSPITAL   (Netherlands)

^b European Reference Laboratory for Glycohemoglobin   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

DIABETES MELLITUS; FLUORESCENCE ANALYSIS; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LETTER; POINT OF CARE TESTING; REPRODUCIBILITY;

HEMOGLOBIN A, GLYCOSYLATED; HUMANS; POINT-OF-CARE SYSTEMS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS;

EID: 77954362531     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2010.143149     Document Type: Letter

References (5)

1. Lenters-Westra E, Slingerland RJ. Six of eight hemoglobin A1c point-of-care instruments do not meet the general accepted analytical performance criteria. Clin Chem 2010;56:44-52.
2. NGSP. List of NGSP certified methods. [Updated 12/09, listed by date certified]. http://www.ngsp.org/prog/methods.pdf (Accessed March 2010).
3. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33:S62-9.
4. NGSP. NGSP protocol: C. standardization and certification of methods by manufacturers. http://www.ngsp.org/prog/protocol/prot.html (Accessed December 2009).
5. Bruns DE, Boyd JC. Few point-of-care hemoglobin A1c assay methods meet clinical needs. Clin Chem 2010;56:4-6.